Minireviews
Copyright ©The Author(s) 2020.
World J Clin Cases. May 26, 2020; 8(10): 1818-1831
Published online May 26, 2020. doi: 10.12998/wjcc.v8.i10.1818
Table 1 Description of telerehabilitation studies
Ref.DesignTR group patientsTR intervention
Outcomes
Remote monitoringExercise prescriptionFeedbackI-primary II-secondary
Avila et al[15], 2018RCT, 12-wk III-phase CR active CBCRn = 30 age 59 I-II CVRPost-exercise, chest strap HR monitor, internet connectionTarget HR zone 70%-80% HRR, 150 min/wkPhone call or email 1/wkI-exercise capacity II-daily PA, strength CVR factors
Bravo-Escobar et al[16], 2017RCT, 8-wk II-phase CR active CBCRn = 14 age 56 II - CVRPost-exercise, ECG, biometric vest, smartphone internetTarget HR zone 70%-80% HRR, 60 min > 2/wkSupervised CR in center 1/wkI-exercise capacity II-CVR factors, HRQL, adherence
Fang et al[17], 2018RCT, 6-wk II-phase CR usual care CGn = 40 age 60 I - CVRReal-time belt strap sensor, smartphone internet connectionPhysical activity booklet, walking 3/wkPhone call 1/wkExercise capacity, anxiety, depression CVR factors
Frederix et al[18], 2015RCT, 24-wk II-III phase CR usual care CGn = 70 age 61Post-exercise accelerometer, webservice, internetTarget HR zone 1VT, 45-60 min 2/wkEmail or SMS 1/wkI-exercise capacity II-daily PA, HRQL, CVR factors
Hwang et al[24], 2017RCT, 12-wk HF-CR active CBCRn = 24 age 68Real-time video platform via internet, educational lecturesTarget RPE zone 9-13 RPE, 60 min 2/wk15 min real-time video feedbackI-walking distance II-balance, strength, HRQL
Kraal et al[19], 2014RCT, 12-wk II-phase CR active CBCRn = 25 age 59 I-II CVRPost-exercise, chest strap HR monitor, internet platformTarget HR zone 70%-85% HRmax 45%-60% min > 2/wkWeekly coaching via telephoneI-exercise capacity II-HRQL, training adherence
Lee et al[20], 2013RCT, 12-wk II-phase CR usual care CGn = 26 age 54 I-II CVRWearable ECG equipment via mobile phoneTarget HR zone 40%-80% HRR, 50 min, 4-5/wkPhone call 1/wkI-exercise capacity II-HRQL
Maddison et al[21], 2019RCT, 12-wk II-phase CR active CBCRn = 82 age 61Chest-worn wearable ECG sensor, internet smartphone app, accelerometryTarget HR and RPE zone 40%-65% HRR, 11-13 RPE 30-60 min, 3/wkReal-time audio service via earphonesI-exercise capacity II-daily PA, HRQL, CVR factors, costs
Peng et al[25], 2018RCT, 8-wk HF-CR usual care CGn = 49 age 66Real-time, HR monitor smartphone, internet platformTarget HR zone 40%-70% HRR 20 min, 3/wkText, audio service via webcamI-HRQL II-walking distance, anxiety, depression
Piotrowicz et al[26], 2014RCT, 8-wk HF-CR usual care CGn = 77 age 54Real-time, ECG, BP and BW monitor, mobile phoneTarget HR zone 40%-70% HRR 45-60 min 5/wkReal-time telephone callI-exercise capacity II-walking distance HRQL, adherence
Skobel et al[22], 2017RCT, 24-wk III-phase CR usual care CGn = 55 age 60Real-time, ECG sensor vest, smartphone, internet platformTarget RPE zone 11-13 RPE, 10-60 min 3/wkReal-time via smartphoneI-exercise capacity II-HRQL, CVR factors, anxiety
Varnfield et al[23], 2014RCT, 24-wk II-phase CR active CBCRn = 53 age 56Post-exercise, step-counter, BP and BW monitor, web portal, internetTarget RPE zone 11-13 RPE, > 30 min most d/wkText message telephone consultation first 6 wkI-uptake, adherence II-HRQL, CVR factors, functional capacity
Table 2 Study quality using Tool for the assEssment of Study qualiTy and reporting in EXercise scale
Ref.Study quality, Max 5Study reporting, Max 10Total score, Max 15
Avila et al[15], 20184913
Bravo-Escobar et al[16], 20174711
Fang et al[17], 2018235
Frederix et al[18], 20155813
Hwang et al[24], 201751015
Kraal et al[19], 20144812
Lee et al[20], 2013235
Maddison et al[21], 20194610
Peng et al[25], 20184711
Piotrowicz et al[26], 20144610
Skobel et al[22], 20175510
Varnfield et al[23], 20144913
Table 3 Studies outcomes
Ref.Follow-up, in weekCompletion rate, %
Adverse events, nExercise capacity between group differencesa
TRCG
Avila et al[15], 201812941001No adverse eventsTR = CBCR
Bravo-Escobar et al[16], 201789310013 angina type pain during TR, no ECG changes; no serious CV eventsTR = CBCR
Fang et al[17], 201868385Not reportedTR > UC
Frederix et al[18], 2015248991Not reportedTR > UC
Hwang et al[24], 201712100901Minor adverse events: 3 angina, 2 palpitation, 3 diaphoresis; no serious CV eventsTR = CBCR
Kraal et al[19], 20141286961No adverse eventsTR = CBCR
Lee et al[20], 2013128797Not reportedTR > UC
Maddison et al[21], 20191288921Mild: 12 non-serious; moderate: 6 medically important event, hospitalization; no serious CV complicationsTR = CBCR
Peng et al[25], 201888684No adverse eventsTR > UC
Piotrowicz et al[26], 201489794Minor: 4 skin reactions due to the ECG electrodes; no serious CV eventsTR > UC
Skobel et al[22], 2017243567No CV events associated to CR adverse events: 9; 2 chest infection, 3 angina, 2 chest pain before training, 1 atrial fibrillation, 1 palpitationTR > UC
Varnfield et al[23], 201469168110 deterioration in health and/or medical care needs unrelated to CR; no serious CV eventsTR = CBCR